Gain from adding Roche's Avastin to immune drug unclear

MADRID (Reuters) - It is too early to say whether combining Roche's best-selling Avastin cancer drug with the company's experimental immune-boosting medicine MPDL3280A gives a better outcome in fighting tumors.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news